GenMont Biotech Inc (景岳生物科技), Taiwan’s leading brand of probiotics, yesterday said it was making an aggressive foray into China as the country’s awareness of healthcare products grows.
The company began talks with Chinese retailers in February about carrying its products and business momentum is expected to pick up substantially next year, the company’s vice executive officer Eddy Hsieh (謝春成) said.
“The market is still being educated on the benefits of probiotics, as Chinese consumers are not familiar with the term,” he said on the sidelines of this year’s Bio Taiwan expo press briefing yesterday.
The company said Chinese consumers do drink sour milk, but they are not very familiar with probiotics — live micro-organisms said to be healthy for the host organism widely used in yogurt and the Yakult-brand drink, which is popular with Taiwanese consumers who want to get probiotics into their daily diet.
As China becomes more health conscious, GenMont aims to tap into the emerging market to sell its slew of probiotic products.
“There are 70 million babies born in China every year, compared with only 190,000 in Taiwan,” Hsieh said, adding that the market across the Taiwan Strait could be a cash cow if the company manages to seize a share of the market.
GenMont is one of 17 Taiwanese firms set to showcase their latest biotech offerings and educate the market on biotech developments during this year’s Bio Taiwan expo, which is scheduled to take place at the Taipei World Trade Center Exhibition Hall I from July 22 to July 25.
PhytoHealth Corp (懷特生技新藥), Taiwan’s first publicly listed biotech firm, is also taking part in the fair to create exposure for its flagship botanical drug — PhytoHealth PG2.
PG2 is the first botanical drug to be approved by Taiwan’s Department of Health.
The new drug has been clinically proven to be safe and efficacious in relieving cancer-related fatigue among advanced cancer patients under standard palliative care.
The company is planning to inject about NT$300 million (US$10 million) into the development of a new facility in Yangmei (楊梅), Taoyuan County, to produce PG2, the mass production of which is expected to begin in the second quarter of next year, assistant researcher Lai Yen-han (賴彥翰) said.
“Most of the drugs on the market now are chemical based, while few botanical ones are proven to be effective,” Lai said.
After securing a foothold in the Taiwanese market for PG2, the company said it plans to get the drug certified by US Food and Drug Administration for overseas export purposes.
According to statistics from the Ministry of Economic Affairs, revenues from the local biotech industry — including those from pharmaceuticals and medical devices — reached US$6.2 billion in 2008, up from US$5.9 billion in 2007.
There were a total of 1,184 biotech companies in Taiwan in 2008, which employed 42,773 people, a rise from 1,116 firms and 40,794 employees in the previous year.
Among the rows of vibrators, rubber torsos and leather harnesses at a Chinese sex toys exhibition in Shanghai this weekend, the beginnings of an artificial intelligence (AI)-driven shift in the industry quietly pulsed. China manufactures about 70 percent of the world’s sex toys, most of it the “hardware” on display at the fair — whether that be technicolor tentacled dildos or hyper-realistic personalized silicone dolls. Yet smart toys have been rising in popularity for some time. Many major European and US brands already offer tech-enhanced products that can enable long-distance love, monitor well-being and even bring people one step closer to
Malaysia’s leader yesterday announced plans to build a massive semiconductor design park, aiming to boost the Southeast Asian nation’s role in the global chip industry. A prominent player in the semiconductor industry for decades, Malaysia accounts for an estimated 13 percent of global back-end manufacturing, according to German tech giant Bosch. Now it wants to go beyond production and emerge as a chip design powerhouse too, Malaysian Prime Minister Anwar Ibrahim said. “I am pleased to announce the largest IC (integrated circuit) Design Park in Southeast Asia, that will house world-class anchor tenants and collaborate with global companies such as Arm [Holdings PLC],”
TRANSFORMATION: Taiwan is now home to the largest Google hardware research and development center outside of the US, thanks to the nation’s economic policies President Tsai Ing-wen (蔡英文) yesterday attended an event marking the opening of Google’s second hardware research and development (R&D) office in Taiwan, which was held at New Taipei City’s Banciao District (板橋). This signals Taiwan’s transformation into the world’s largest Google hardware research and development center outside of the US, validating the nation’s economic policy in the past eight years, she said. The “five plus two” innovative industries policy, “six core strategic industries” initiative and infrastructure projects have grown the national industry and established resilient supply chains that withstood the COVID-19 pandemic, Tsai said. Taiwan has improved investment conditions of the domestic economy
Sales in the retail, and food and beverage sectors last month continued to rise, increasing 0.7 percent and 13.6 percent respectively from a year earlier, setting record highs for the month of March, the Ministry of Economic Affairs said yesterday. Sales in the wholesale sector also grew last month by 4.6 annually, mainly due to the business opportunities for emerging applications related to artificial intelligence (AI) and high-performance computing technologies, the ministry said in a report. The ministry forecast that retail, and food and beverage sales this month would retain their growth momentum as the former would benefit from Tomb Sweeping Day